These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23260686)

  • 21. Diagnosis and management of gonococcal infections.
    Mayor MT; Roett MA; Uduhiri KA
    Am Fam Physician; 2012 Nov; 86(10):931-8. PubMed ID: 23157146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020.
    St Cyr S; Barbee L; Workowski KA; Bachmann LH; Pham C; Schlanger K; Torrone E; Weinstock H; Kersh EN; Thorpe P
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1911-1916. PubMed ID: 33332296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England.
    Chisholm SA; Wilson J; Alexander S; Tripodo F; Al-Shahib A; Schaefer U; Lythgow K; Fifer H
    Sex Transm Infect; 2016 Aug; 92(5):365-7. PubMed ID: 26601852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In brief: New recommendations for gonococcal infection.
    Med Lett Drugs Ther; 2021 May; 63(1623):72. PubMed ID: 33976101
    [No Abstract]   [Full Text] [Related]  

  • 25. First line dual therapy for gonorrhoea to limit the spread of antimicrobial resistance.
    Mohammed H; Sile B; Furegato M; Woodhall S; Fifer H; Hughes G
    BMJ; 2017 Feb; 356():j565. PubMed ID: 28153820
    [No Abstract]   [Full Text] [Related]  

  • 26. Committee Opinion No. 645: Dual Therapy for Gonococcal Infections.
    Obstet Gynecol; 2016 May; 127(5):e95-9. PubMed ID: 27548425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
    Singh AE; Gratrix J; Read R; Lovgren M; Drews SJ; Romanowski B; Sutherland K; Talbot J; Martin I
    Sex Transm Dis; 2013 Sep; 40(9):744-50. PubMed ID: 23945428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.
    Ison CA; Town K; Obi C; Chisholm S; Hughes G; Livermore DM; Lowndes CM;
    Lancet Infect Dis; 2013 Sep; 13(9):762-8. PubMed ID: 23764300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
    Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
    J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonorrhoea treatment position statement.
    Fifer H; Hughes G; Radcliffe K
    Sex Transm Infect; 2015 Aug; 91(5):307. PubMed ID: 26195472
    [No Abstract]   [Full Text] [Related]  

  • 31. Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina.
    Gianecini R; Oviedo C; Stafforini G; Galarza P
    Emerg Infect Dis; 2016 Jun; 22(6):1139-41. PubMed ID: 27191699
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neisseria gonorrhoeae infections].
    Furuya R; Tanaka M
    Nihon Rinsho; 2009 Jan; 67(1):129-35. PubMed ID: 19177762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of azithromycin 2.0 g in the treatment of gonococcal urethritis caused by high-level resistance in California.
    Gose SO; Soge OO; Beebe JL; Nguyen D; Stoltey JE; Bauer HM
    Sex Transm Dis; 2015 May; 42(5):279-80. PubMed ID: 25868141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential deleterious effects of promoting the use of ceftriaxone in the treatment of Neisseria gonorrhoeae.
    Golden MR; Barbee LA; Kerani R; Dombrowski JC
    Sex Transm Dis; 2014 Oct; 41(10):619-25. PubMed ID: 25211259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
    Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
    Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Gonorrhea in Adolescents and Adults in the United States.
    Kidd S; Workowski KA
    Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S785-801. PubMed ID: 26602618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
    Tapsall JW
    Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence and spread of drug resistant Neisseria gonorrhoeae.
    Deguchi T; Nakane K; Yasuda M; Maeda S
    J Urol; 2010 Sep; 184(3):851-8; quiz 1235. PubMed ID: 20643433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness of Dual Antimicrobial Therapy for Gonococcal Infections Among Men Who Have Sex With Men in the Netherlands.
    Xiridou M; Lugnér A; de Vries HJ; van Bergen JE; Götz HM; van Benthem BH; Wallinga J; van der Sande MA
    Sex Transm Dis; 2016 Sep; 43(9):542-8. PubMed ID: 27513379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antimicrobal resistance of Neisseria gonorrhoeae strains in Hungary].
    Nemes-Nikodém É; Brunner A; Tóth B; Tóth V; Bánvölgyi A; Ostorházi E
    Orv Hetil; 2015 Feb; 156(6):226-9. PubMed ID: 25639637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.